Lipid Insights

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to stay at the forefront of lipidology!

Lipid Insights is a health podcast hosted by National Lipid Association, with 48 episodes on record and a Required Pod Score of 80.

National Lipid Association hosts Lipid Insights, a health show with 48 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #11

  S7E11: Catching FH Early: Point-of-Care Testing in 2-Year-Olds

  Sep 24, 202622 minS7

  In honor of FH Awareness Day, this special Lipid Insights episode features a conversation with Jose Lopez, MS, recipient of the Donald Hunninghake, MD, Familial Hypercholesterolemia (FH) Abstract Award at the 2026 NLA Scientific Sessions. Guest host and Foundation of the NLA President Ann Liebeskind, MD, FNLA, FAAP sits down with Jose to discuss his award-winning abstract, "Early Detection of Familial Hypercholesterolemia Through Point of Care Testing in 2-Year-Olds" — exploring the promise of point-of-care lipid testing in very young children as a practical strategy for identifying FH. A timely and important listen for any clinician committed to closing the gap in FH detection. Watch the video version on YouTube HERE .

  ListenShow Notes
• 

  Lipid Insights

  From Cholesterol to Dyslipidemia: Why the Dyslipidemia Guideline Had to Change | Episode 1

  Sep 14, 202646 min

  The 2026 Multi-Society Dyslipidemia Guideline introduced significant changes; but, this episode isn't just about what's new. It's about why the field decided a change was necessary in the first place. In the first installment of this four-part CME/CE-accredited series, host Dave Dixon, PharmD, CLS, FNLA sits down with NLA President Dinesh Kalra, MD, FNLA and Salim Virani, MD to unpack the foundational shift from cholesterol-focused care to a broader dyslipidemia paradigm. The conversation covers why atherogenic lipoprotein exposure earlier in life matters, the key clinical misconceptions embedded in the prior guideline, and what clinicians most commonly misunderstand about lipid risk. This episode is a companion piece to the Month 1 webinar, From Cholesterol to Dyslipidemia: What Changed in the 2026 Guideline ? We encourage you to check it out as the two were built to work together: https://youtu.be/9v4WBVfKsho . CME/CE Credit: This activity has been approved for AMA PRA Category 1 Credit and is eligible for ACPE, ANCC, and CDR credit. CME/CE credit is provided by the National Lipid Association. Claim your credit and complete the activity assessment at lipid.org/lipidinsights. Questions? Contact CME@lipid.org .

  ListenShow Notes
• 

  Episode #10

  S7E10: Fresh from Munich: Plozasiran and the SHASTA-3 & SHASTA-4 Trial Results

  Sep 4, 202616 minS7

  Hot off the European Society of Cardiology Congress in Munich, this Lipid Insights episode takes a closer look at a significant announcement in triglyceride science and its implications for clinical practice. Host Peter H. Jones, MD, MNLA sits down with Christie M. Ballantyne, MD, MNLA to discuss the 12-month pivotal trial results from SHASTA-3 and SHASTA-4 — evaluating plozasiran in patients with severe hypertriglyceridemia. If you missed Munich, this is your catch-up. Watch the video version on YouTube HERE .

  ListenShow Notes
• 

  Episode #8

  S7E8: Thinking Long-Term: LDL Exposure, Longevity Medicine, and the Future of Cardiovascular Prevention

  Jul 1, 202628 minS7

  How do we move the needle on cardiovascular prevention — not just in the clinic, but across entire systems and communities? In this episode of Lipid Insights, host Alan S. Brown, MD, MHA, MNLA sits down with Nihar R. Desai, MD, MPH, FNLA for a forward-thinking conversation on long-term LDL exposure and what it truly means to practice longevity medicine. From the power of imaging as a patient education tool to the momentum behind the 2026 dyslipidemia guidelines, Dr. Desai shares his vision for a healthcare landscape where patients are empowered, systems are hardwired to deliver better care, and public education closes the gap between what we know and what gets done. A timely and thought-provoking listen for any clinician committed to moving cardiovascular prevention forward.

  ListenShow Notes
• 

  Episode #7

  S7E7: National Lipid Day Special: The Lipid Doctor’s Truths Every Clinician Should Know

  May 10, 202658 minS7

  <p>What does your patient's lipid panel actually tell you and what is it missing? In this special National Lipid Day episode of Lipid Insights, host Peter H. Jones, MD, MNLA, sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as "The Lipid Doctor" — for a conversation that challenges some of medicine's most entrenched assumptions about lipid risk assessment. From the clinical superiority of ApoB over LDL-C and the underrecognized atherogenic burden of Lipoprotein(a), to why HDL-C should no longer be treated as a therapeutic target, Dr. Dayspring delivers evidence-based truths that have direct implications for how clinicians asse...

  ListenShow Notes

Recent guests on Lipid Insights. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.